Product Code: PHA1263
The global Precision Medicine market is projected to grow at a CAGR of 11.0% by 2033.
“The Precision Medicine Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Expanding Applications of Precision Medicine and Rising Demand for Targeted Therapy
With regard to genetic disorders, precision medicine is becoming more prevalent. In the domains of neurogenetics, cardiovascular genomics, and rare illness genetic testing, this method is being employed more frequently. Additionally, non-invasive prenatal testing, pharmacogenomics, and screening genetic risk for hereditary diseases are also becoming more prevalent applications of precision medicine. A number of pharmaceutical companies are also concentrating on the creation of precision medicine for neurological conditions like Alzheimer's and Parkinson's disease. Pharmacological, biopharmaceutical, and pharmaceutical firms are continuously working to integrate patient-selection diagnostic frameworks into the earlier phases of drug development in order to deliver targeted therapies to the appropriate candidate and support the expansion of the precision medicine market. One of the main causes of the expanding usage of genomes and proteomics technologies as well as precision medicine is the increased understanding of the advantages of personalised medicine. Individualised treatment plans for many chronic diseases and conditions must include precision medicine, which entails the investigation of specific indications for particular medications in a given patient.
High Cost of Precision Medicine
Although personalized treatments are well-established in the pharmaceutical business, their cost continues to prevent payers, patients, and doctors from accessing them. Despite offering guaranteed returns on investment, the high initial cost of these tests makes them inaccessible to a huge majority of end users, particularly those in poor nations. As a result, end users like pharmaceutical firms, reference labs, medical facilities, and CROs who view the cost of such diagnostic procedures as a burden choose to use third-party precision diagnostic services. Inevitably, current medical privacy and investigation guidelines are inadequate to allow for the collection of enormous amounts of data on large patient populations, and private healthcare systems lack the infrastructure to do so, which drives up the price of precision medicine even more.
What Questions Should You Ask before buying a Market Research Report?
- How is the precision medicine market evolving?
- What is driving and restraining the precision medicine market?
- How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each precision medicine submarket develop from 2022 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading precision medicine markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the precision medicine projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of precision medicine projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the precision medicine market?
- Where is the precision medicine market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Precision Medicine market today, and over the next 10 years:
- Our 347-page report provides 149 tables, 220 charts, and graphs exclusively to you
- The report highlights key lucrative areas in the industry so you can target them - NOW
- It contains in-depth analysis of global, regional and national sales and growth
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Precision Medicine market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
- You will find original analyses, with business outlooks and developments
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Precision Medicine prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report:
Product
- Diagnostic
- Genetic Tests
- Biomarker Based Tests
- Other Diagnostic Tests
Application
- Oncology
- CNS
- Immunology
- Respiratory
- Others
Technology
- Drug Discovery
- Bioinformatics
- Big Data Analytics
- Gene Sequencing
- Companion Diagnostics
- Other Technologies
End-user
- Hospitals
- Diagnostic Centres
- Research & Academic Institutes
- Other End-users
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:
North America
Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
MEA
- GCC
- South Africa
- Egypt
- Rest of MEA
The report also includes profiles and for some of the leading companies in the Precision Medicine Market, 2023 to 2033, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth:
- Abbott
- Abnova Corporation
- Agilent Technologies Inc
- AstraZeneca
- Bayer AG
- Biogen
- bioMerieux SA
- Bristol-Myers Squibb Company
- Danaher
- F. Hoffmann-La Roche Ltd
- GE HealthCare
- GSK plc
|
- Illumina, Inc
- Johnson & Johnson Services, Inc
- Laboratory Corporation of America Holdings
- Lilly
- Myriad Genetics Inc
- NanoString Technologies, Inc
- Novartis AG
- Pfizer Inc
- Qiagen
- Quest Diagnostics Incorporated
- Teva Pharmaceutical Industries Ltd
- Thermo Fisher Scientific Inc.
|
Overall world revenue for Precision Medicine Market, 2023 to 2033 in terms of value the market will surpass US$78 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Precision Medicine Market, 2023 to 2033 report help you?
In summary, our 340+ page report provides you with the following knowledge:
- Revenue forecasts to 2033 for Precision Medicine Market, 2023 to 2033 Market, with forecasts for product, mode, sample, platform, end user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 25 key national markets - See forecasts for the Precision Medicine Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, Singapore, Argentina, GCC, South Africa, and Egypt among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Precision Medicine Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Precision Medicine Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Precision Medicine Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Reports
- 1.10 About
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 Increasing Global Burden of Cancer Boosts the Demand for Personalized Medicine
- 3.2.1.2 Increase in Scope of Application of Precision Medicine
- 3.2.1.3 Accelerating Demand for Targeted Therapy
- 3.2.1.4 Growing Precedence of Precision Medicine Over Traditional Practice of "One-Size-Fits-All" Therapies
- 3.2.2 Market Restraining Factors
- 3.2.2.1 High Cost of Precision Medicine
- 3.2.2.2 Lack of Data Interoperability
- 3.2.2.3 Insufficient Funding for Diagnostics Space in the Emerging Economies
- 3.2.3 Market Opportunities
- 3.2.3.1 Growing Use of AI in Healthcare Is Boosting Demand for Precision Medicine
- 3.2.3.2 Growing acceptance of gene therapy and gene editing technology
- 3.3 COVID-19 Impact Analysis
- 3.4 Porter's Five Forces Analysis
- 3.4.1 Bargaining Power of Supplier
- 3.4.2 Bargaining Power of Buyers
- 3.4.3 Threat of New Entrants
- 3.4.4 Threat from Substitutes
- 3.4.5 Competitive Rivalry
- 3.5 SWOT Analysis
- 3.6 PEST Analysis
4 Precision Medicine Market Analysis by Product Type
- 4.1 Key Findings
- 4.2 Product Type Segment: Market Attractiveness Index
- 4.3 Precision Medicine Market Size Estimation and Forecast by Product Type
- 4.4 Diagnostics
- 4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 4.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.4.3 Genetic Tests
- 4.4.3.1 Market Size by Region, 2023-2033 (US$ Billion)
- 4.4.3.2 Market Share by Region, 2023 & 2033 (%)
- 4.4.4 Biomarker Based Tests
- 4.4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 4.4.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.4.5 Others
- 4.4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 4.4.5.2 Market Share by Region, 2023 & 2033 (%)
- 4.5 Therapeutics
- 4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 4.5.2 Market Share by Region, 2023 & 2033 (%)
5 Precision Medicine Market, by Application, 2023-2033
- 5.1 Key Findings
- 5.2 Application Segment: Market Attractiveness Index
- 5.3 Precision Medicine Market, by Application
- 5.4 Oncology
- 5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 5.4.2 Market Share by Region, 2023 & 2033 (%)
- 5.5 CNS
- 5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 5.5.2 Market Share by Region, 2023 & 2033 (%)
- 5.6 Immunology
- 5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
- 5.6.2 Market Share by Region, 2023 & 2033 (%)
- 5.7 Respiratory
- 5.7.1 Market Size by Region, 2023-2033 (US$ Billion)
- 5.7.2 Market Share by Region, 2023 & 2033 (%)
- 5.8 Others
- 5.8.1 Market Size by Region, 2023-2033 (US$ Billion)
- 5.8.2 Market Share by Region, 2023 & 2033 (%)
6 Precision Medicine Market, by Technology, 2023-2033
- 6.1 Key Findings
- 6.2 Technology Segment: Market Attractiveness Index
- 6.3 Precision Medicine Market Size Estimation and Forecast by Technology
- 6.4 Drug Discovery
- 6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.4.2 Market Share by Region, 2023 & 2033 (%)
- 6.5 Bioinformatics
- 6.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.5.2 Market Share by Region, 2023 & 2033 (%)
- 6.6 Big Data Analytics
- 6.6.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.6.2 Market Share by Region, 2023 & 2033 (%)
- 6.7 Gene Sequencing
- 6.7.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.7.2 Market Share by Region, 2023 & 2033 (%)
- 6.8 Companion Diagnostics
- 6.8.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.8.2 Market Share by Region, 2023 & 2033 (%)
- 6.9 Other Technologies
- 6.9.1 Market Size by Region, 2023-2033 (US$ Billion)
- 6.9.2 Market Share by Region, 2023 & 2033 (%)
7 Precision Medicine Market, by End-users, 2023-2033
- 7.1 Key Findings
- 7.2 End-users Segment: Market Attractiveness Index
- 7.3 Precision Medicine Market Size Estimation and Forecast by End-users
- 7.4 Hospitals
- 7.4.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.4.2 Market Share by Region, 2023 & 2033 (%)
- 7.5 Diagnostic centres
- 7.5.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.5.2 Market Share by Region, 2023 & 2033 (%)
- 7.6 Research & Academic Institutes
- 7.6.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.6.2 Market Share by Region, 2023 & 2033 (%)
- 7.7 Other End-users
- 7.7.1 Market Size by Region, 2023-2033 (US$ Billion)
- 7.7.2 Market Share by Region, 2023 & 2033 (%)
8 Precision Medicine Market Analysis by Region
- 8.1 Key Findings
- 8.2 Regional Market Size Estimation and Forecast
9 North America Precision Medicine Market Analysis
- 9.1 Key Findings
- 9.2 North America Precision Medicine Market Attractiveness Index
- 9.3 North America Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
- 9.4 North America Precision Medicine Market Size Estimation and Forecast by Country
- 9.5 North America Precision Medicine Market Size Estimation and Forecast by Product Type
- 9.6 North America Precision Medicine Market Size Estimation and Forecast by Application
- 9.7 North America Precision Medicine Market Size Estimation and Forecast by Technology
- 9.8 North America Precision Medicine Market Size Estimation and Forecast by End-users
- 9.9 U.S. Precision Medicine Market Analysis
- 9.10 Canada Precision Medicine Market Analysis
10 Europe Precision Medicine Market, 2023-2033
- 10.1 Key Findings
- 10.2 Europe Precision Medicine Market Attractiveness Index
- 10.3 Europe Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
- 10.4 Europe Precision Medicine Market Size Estimation and Forecast by Country
- 10.5 Europe Precision Medicine Market Size Estimation and Forecast by Product Type
- 10.6 Europe Precision Medicine Market Size Estimation and Forecast by Application
- 10.7 Europe Precision Medicine Market Size Estimation and Forecast by Technology
- 10.8 Europe Precision Medicine Market Size Estimation and Forecast by End-users
- 10.9 Germany Precision Medicine Market Analysis
- 10.10 UK Precision Medicine Market Analysis
- 10.11 France Precision Medicine Market Analysis
- 10.12 Italy Precision Medicine Market Analysis
- 10.13 Spain Precision Medicine Market Analysis
- 10.14 Switzerland Precision Medicine Market Analysis
- 10.15 Netherlands Precision Medicine Market Analysis
- 10.16 Rest of Europe Precision Medicine Market Analysis
11 Asia Pacific Precision Medicine Market Analysis
- 11.1 Key Findings
- 11.2 Asia Pacific Precision Medicine Market Attractiveness Index
- 11.3 Asia Pacific Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
- 11.4 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Country
- 11.5 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Product Type
- 11.6 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Application
- 11.7 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Technology
- 11.8 Asia Pacific Precision Medicine Market Size Estimation and Forecast by End-users
- 11.9 Japan Precision Medicine Market Analysis
- 11.10 China Precision Medicine Market Analysis
- 11.11 India Precision Medicine Market Analysis
- 11.12 Australia Precision Medicine Market Analysis
- 11.13 South Korea Precision Medicine Market Analysis
- 11.14 Singapore Precision Medicine Market Analysis
- 11.15 Rest of Asia Pacific Precision Medicine Market Analysis
12 Latin America Precision Medicine Market Analysis
- 12.1 Key Findings
- 12.2 Latin America Precision Medicine Market Attractiveness Index
- 12.3 Latin America Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
- 12.4 Latin America Precision Medicine Market Size Estimation and Forecast by Country
- 12.5 Latin America Precision Medicine Market Size Estimation and Forecast by Product Type
- 12.6 Latin America Precision Medicine Market Size Estimation and Forecast by Application
- 12.7 Latin America Precision Medicine Market Size Estimation and Forecast by Technology
- 12.8 Latin America Precision Medicine Market Size Estimation and Forecast by End-users
- 12.9 Brazil Precision Medicine Market Analysis
- 12.10 Mexico Precision Medicine Market Analysis
- 12.11 Argentina Precision Medicine Market Analysis
- 12.12 Rest of Latin America Precision Medicine Market Analysis
13 MEA Precision Medicine Market Analysis
- 13.1 Key Findings
- 13.2 MEA Precision Medicine Market Attractiveness Index
- 13.3 MEA Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
- 13.4 MEA Precision Medicine Market Size Estimation and Forecast by Country
- 13.5 MEA Precision Medicine Market Size Estimation and Forecast by Product Type
- 13.6 MEA Precision Medicine Market Size Estimation and Forecast by Application
- 13.7 MEA Precision Medicine Market Size Estimation and Forecast by Technology
- 13.8 MEA Precision Medicine Market Size Estimation and Forecast by End-users
- 13.9 GCC Precision Medicine Market Analysis
- 13.10 South Africa Precision Medicine Market Analysis
- 13.11 Egypt Precision Medicine Market Analysis
- 13.12 Rest of MEA Precision Medicine Market Analysis
14 Company Profiles
- 14.1 Competitive Landscape, 2022
- 14.2 Pfizer Inc.
- 14.2.1 Company Snapshot
- 14.2.2 Company Overview
- 14.2.3 Financial Analysis
- 14.2.3.1 Net Revenue, 2018-2022
- 14.2.3.2 R&D, 2018-2022
- 14.2.3.3 Regional Market Shares, 2022
- 14.2.4 Product Benchmarking
- 14.2.5 Strategic Outlook
- 14.3 Qiagen
- 14.3.1 Company Snapshot
- 14.3.2 Company Overview
- 14.3.3 Financial Analysis
- 14.3.3.1 Net Revenue, 2018-2022
- 14.3.3.2 R&D, 2018-2022
- 14.3.3.3 Regional Market Shares, 2022
- 14.3.4 Product Benchmarking
- 14.3.5 Strategic Outlook
- 14.4 Quest Diagnostics Incorporated
- 14.4.1 Company Snapshot
- 14.4.2 Company Overview
- 14.4.3 Financial Analysis
- 14.4.3.1 Net Revenue, 2018-2022
- 14.4.4 Product Benchmarking
- 14.4.5 Strategic Outlook
- 14.5 Agilent Technologies Inc.
- 14.5.1 Company Snapshot
- 14.5.2 Company Overview
- 14.5.3 Financial Analysis
- 14.5.3.1 Net Revenue, 2018-2022
- 14.5.3.2 R&D, 2018-2022
- 14.5.3.3 Regional Market Shares, 2022
- 14.5.4 Product Benchmarking
- 14.5.5 Strategic Outlook
- 14.6 Illumina, Inc.
- 14.6.1 Company Snapshot
- 14.6.2 Company Overview
- 14.6.3 Financial Analysis
- 14.6.3.1 Net Revenue, 2018-2022
- 14.6.3.2 R&D, 2018-2022
- 14.6.3.3 Regional Market Shares, 2022
- 14.6.4 Product Benchmarking
- 14.6.5 Strategic Outlook
- 14.7 Novartis AG
- 14.7.1 Company Snapshot
- 14.7.2 Company Overview
- 14.7.3 Financial Analysis
- 14.7.3.1 Net Revenue, 2018-2022
- 14.7.3.2 R&D, 2018-2022
- 14.7.3.3 Regional Market Shares, 2022
- 14.7.4 Product Benchmarking
- 14.7.5 Strategic Outlook
- 14.8 bioMerieux SA
- 14.8.1 Company Snapshot
- 14.8.2 Company Overview
- 14.8.3 Financial Analysis
- 14.8.3.1 Net Revenue, 2018-2022
- 14.8.3.2 R&D, 2018-2022
- 14.8.3.3 Regional Market Shares, 2022
- 14.8.4 Product Benchmarking
- 14.8.5 Strategic Outlook
- 14.9 F. Hoffmann-La Roche Ltd
- 14.9.1 Company Snapshot
- 14.9.2 Company Overview
- 14.9.3 Financial Analysis
- 14.9.3.1 Net Revenue, 2018-2022
- 14.9.3.2 R&D, 2018-2022
- 14.9.3.3 Regional Market Shares, 2022
- 14.9.4 Product Benchmarking
- 14.9.5 Strategic Outlook
- 14.10 Abbott
- 14.10.1 Company Snapshot
- 14.10.2 Company Overview
- 14.10.3 Financial Analysis
- 14.10.3.1 Net Revenue, 2018-2022
- 14.10.3.2 R&D, 2018-2022
- 14.10.3.3 Regional Market Shares, 2022
- 14.10.4 Product Benchmarking
- 14.10.5 Strategic Outlook
- 14.11 Lilly
- 14.11.1 Company Snapshot
- 14.11.2 Company Overview
- 14.11.3 Financial Analysis
- 14.11.3.1 Net Revenue, 2018-2022
- 14.11.3.2 R&D, 2018-2022
- 14.11.3.3 Regional Market Shares, 2022
- 14.11.4 Product Benchmarking
- 14.11.5 Strategic Outlook
- 14.12 Thermo Fisher Scientific Inc.
- 14.12.1 Company Snapshot
- 14.12.2 Company Overview
- 14.12.3 Financial Analysis
- 14.12.3.1 Net Revenue, 2018-2022
- 14.12.3.2 R&D, 2018-2022
- 14.12.3.3 Regional Market Shares, 2022
- 14.12.4 Product Benchmarking
- 14.12.5 Strategic Outlook
- 14.13 AstraZeneca
- 14.13.1 Company Snapshot
- 14.13.2 Company Overview
- 14.13.3 Financial Analysis
- 14.13.3.1 Net Revenue, 2018-2022
- 14.13.3.2 R&D, 2018-2022
- 14.13.3.3 Regional Market Shares, 2022
- 14.13.4 Product Benchmarking
- 14.13.5 Strategic Outlook
- 14.14 Myriad Genetics Inc
- 14.14.1 Company Snapshot
- 14.14.2 Company Overview
- 14.14.3 Financial Analysis
- 14.14.3.1 Net Revenue, 2018-2022
- 14.14.3.2 R&D, 2018-2022
- 14.14.3.3 Regional Market Shares, 2022
- 14.14.4 Product Benchmarking
- 14.14.5 Strategic Outlook
- 14.15 GSK plc
- 14.15.1 Company Snapshot
- 14.15.2 Company Overview
- 14.15.3 Financial Analysis
- 14.15.3.1 Net Revenue, 2018-2022
- 14.15.3.2 R&D, 2018-2022
- 14.15.3.3 Regional Market Shares, 2022
- 14.15.4 Product Benchmarking
- 14.15.5 Strategic Outlook
- 14.16 Bristol-Myers Squibb Company
- 14.16.1 Company Snapshot
- 14.16.2 Company Overview
- 14.16.3 Financial Analysis
- 14.16.3.1 Net Revenue, 2018-2022
- 14.16.3.2 R&D, 2018-2022
- 14.16.3.3 Regional Market Shares, 2022
- 14.16.4 Product Benchmarking
- 14.16.5 Strategic Outlook
- 14.17 Danaher
- 14.17.1 Company Snapshot
- 14.17.2 Company Overview
- 14.17.3 Financial Analysis
- 14.17.3.1 Net Revenue, 2018-2022
- 14.17.3.2 R&D, 2018-2022
- 14.17.3.3 Regional Market Shares, 2022
- 14.17.4 Product Benchmarking
- 14.17.5 Strategic Outlook
- 14.18 Laboratory Corporation of America Holdings
- 14.18.1 Company Snapshot
- 14.18.2 Company Overview
- 14.18.3 Financial Analysis
- 14.18.3.1 Net Revenue, 2018-2022
- 14.18.3.2 Regional Market Shares, 2022
- 14.18.4 Product Benchmarking
- 14.18.5 Strategic Outlook
- 14.19 GE HealthCare
- 14.19.1 Company Snapshot
- 14.19.2 Company Overview
- 14.19.3 Financial Analysis
- 14.19.3.1 Net Revenue, 2018-2022
- 14.19.3.2 Regional Market Shares, 2022
- 14.19.4 Product Benchmarking
- 14.19.5 Strategic Outlook
- 14.20 Teva Pharmaceutical Industries Ltd.
- 14.20.1 Company Snapshot
- 14.20.2 Company Overview
- 14.20.3 Financial Analysis
- 14.20.3.1 Net Revenue, 2018-2022
- 14.20.3.2 R&D, 2018-2022
- 14.20.3.3 Regional Market Shares, 2022
- 14.20.4 Product Benchmarking
- 14.20.5 Strategic Outlook
- 14.21 NanoString Technologies, Inc.
- 14.21.1 Company Snapshot
- 14.21.2 Company Overview
- 14.21.3 Financial Analysis
- 14.21.3.1 Net Revenue, 2018-2022
- 14.21.3.2 R&D, 2018-2022
- 14.21.3.3 Regional Market Shares, 2022
- 14.21.4 Product Benchmarking
- 14.21.5 Strategic Outlook
- 14.22 Bayer AG
- 14.22.1 Company Snapshot
- 14.22.2 Company Overview
- 14.22.3 Financial Analysis
- 14.22.3.1 Net Revenue, 2018-2022
- 14.22.3.2 R&D, 2018-2022
- 14.22.3.3 Regional Market Shares, 2022
- 14.22.4 Product Benchmarking
- 14.22.5 Strategic Outlook
- 14.23 Biogen
- 14.23.1 Company Snapshot
- 14.23.2 Company Overview
- 14.23.3 Financial Analysis
- 14.23.3.1 Net Revenue, 2018-2022
- 14.23.3.2 R&D, 2018-2022
- 14.23.3.3 Regional Market Shares, 2022
- 14.23.4 Product Benchmarking
- 14.23.5 Strategic Outlook
- 14.24 Johnson & Johnson Services, Inc.
- 14.24.1 Company Snapshot
- 14.24.2 Company Overview
- 14.24.3 Financial Analysis
- 14.24.3.1 Net Revenue, 2018-2022
- 14.24.3.2 R&D, 2018-2022
- 14.24.3.3 Regional Market Shares, 2022
- 14.24.4 Product Benchmarking
- 14.24.5 Strategic Outlook
15 Conclusion and Recommendations
- 15.1 Concluding Remarks from
- 15.2 Recommendations for Market Players